-
1
-
-
0030175723
-
Evidence of an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis
-
Gohlke F, Lohse AW, Dienes HP, et al. Evidence of an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol 1996; 24: 699-705.
-
(1996)
J Hepatol
, vol.24
, pp. 699-705
-
-
Gohlke, F.1
Lohse, A.W.2
Dienes, H.P.3
-
3
-
-
0028886210
-
Primary sclerosing cholangitis in 32 children: Clinical, laboratory and radiographie features with survival analysis
-
Wilchanski M, Chait P, Wade JA, et al. Primary sclerosing cholangitis in 32 children: clinical, laboratory and radiographie features with survival analysis. Hepatology 1995; 22: 1415-22.
-
(1995)
Hepatology
, vol.22
, pp. 1415-1422
-
-
Wilchanski, M.1
Chait, P.2
Wade, J.A.3
-
4
-
-
7344263962
-
Autoimmune sclerosing cholangitis: A distinct subset of childhood autoimmune liver disease [abstract]
-
Gregorio GV, Portmann B, Karani J, Vergani D, Mieli-Vergani G. Autoimmune sclerosing cholangitis: a distinct subset of childhood autoimmune liver disease [abstract]. Hepatology 1996; 24: 170A.
-
(1996)
Hepatology
, vol.24
-
-
Gregorio, G.V.1
Portmann, B.2
Karani, J.3
Vergani, D.4
Mieli-Vergani, G.5
-
5
-
-
0031055029
-
Alcohol dehydrogenase: A target of humoral autoimmune response in liver disease
-
Ma Y, et al. Alcohol dehydrogenase: a target of humoral autoimmune response in liver disease. Gastroenterology 1997; 112: 48392.
-
(1997)
Gastroenterology
, vol.112
, pp. 48392
-
-
Ma, Y.1
-
6
-
-
0024512001
-
Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood
-
Mieli-Vergani G, Lobo-Yeo A, McFarlane BM, et al. Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood. Hepatology 1989; 9: 98-203.
-
(1989)
Hepatology
, vol.9
, pp. 98-203
-
-
Mieli-Vergani, G.1
Lobo-Yeo, A.2
McFarlane, B.M.3
-
7
-
-
0028910908
-
Primary sclerosing cholangitis
-
Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995; 332: 924-33.
-
(1995)
N Engl J Med
, vol.332
, pp. 924-933
-
-
Lee, Y.M.1
Kaplan, M.M.2
-
8
-
-
0026730984
-
Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo-controlled trial
-
Beuers U, Spengler U, Kruis W, et al. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology 1992; 16: 707-14.
-
(1992)
Hepatology
, vol.16
, pp. 707-714
-
-
Beuers, U.1
Spengler, U.2
Kruis, W.3
-
9
-
-
0031047361
-
Ursodiol for primary sclerosing cholangitis
-
Lindor KD for the Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. Ursodiol for primary sclerosing cholangitis. N Engl J Med 1997; 336: 691-4.
-
(1997)
N Engl J Med
, vol.336
, pp. 691-694
-
-
Lindor, K.D.1
-
10
-
-
0028085138
-
Sclerosing cholangitis in children
-
Debray D, Pariente D, Urvoas E, Hadchouel M, Bernard O. Sclerosing cholangitis in children. J Pediatr 1994; 124: 49-56.
-
(1994)
J Pediatr
, vol.124
, pp. 49-56
-
-
Debray, D.1
Pariente, D.2
Urvoas, E.3
Hadchouel, M.4
Bernard, O.5
|